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Abstract
Opium has been cultivated in Afghanistan since 1100 A.D., although production has steadily
increased since 1979. Currently, Afghanistan produces three-quarters of the global opium supply,
with injection drug use and HIV currently following the opium trade route through Central Asia.
Although systematic studies are lacking, heroin use appears to be on the rise in Afghanistan. The
purpose of this paper is to briefly provide historical background and current statistics for drug
production and use in Afghanistan, to discuss the new government's policies towards problem drug
use and available rehabilitation programs, and to assess Afghan harm reduction needs with
consideration of regional trends.
Introduction
Afghanistan is at a cross-roads; the country is emerging
from more than twenty years of political and social unrest
as the leading global producer of opium in a geographic
region widely affected by drug use, particularly injection
drug use, and blood-borne infections, including human
immunodeficiency virus (HIV). Countries bordering
Afghanistan (with the exception of Turkmenistan, for
which there is no available data) are experiencing concen-
trated epidemics of HIV and hepatitis C in IDU popula-
tions [1-4]. Afghanistan is currently at risk for these
potentially destabilizing events. Historically, countries
slow to respond or instituting only punitive measures for
ascending rates of drug use have experienced dramatic
outbreaks of HIV and hepatitis among injection drug
users (IDU), often with diffusion into the general popula-
tion [5-7]. The rationale for this paper is to examine the
current situation and policy of Afghanistan, as little is
known about substance abuse in this country. We will
briefly provide historical background and current statis-
tics for drug production and use in Afghanistan, present
the new government's policies towards problem drug use
and available rehabilitation programs, and compare the
situation in Afghanistan to that of the surrounding geo-
graphic region, much of which is experiencing the most
rapid increase of HIV cases due to injection drug use.
Opium History in Afghanistan
We will focus on opium, the substance with greatest
impact on risk of blood borne infections in Afghanistan.
Information was obtained from electronic searches
through PubMed and Google, with additional informa-
tion obtained through site-specific searches, such as
United Nations Office of Drugs and Crime (UNODC).
Selected search words were: opium, Afghanistan, traffick-
ing, Central Asia, and heroin. While we have chosen to
focus only on opium, the same routes for trafficking
opium are used to transport both other illicit substances,
such as cannabis/hashish (also produced in Afghanistan)
and amphetamines and licit drugs of abuse, such as phar-
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analgesics), and volatile inhalants.
Afghanistan, along with Pakistan and Iran, form the
Golden Crescent, an area known for opium and cannabis
cultivation and trafficking from the time poppies were
introduced from Europe by Arab traders along the Silk
Road [8]. Opium production in Afghanistan did not reach
large scale until the Russian invasion in 1979. The growth
in production was attributed to direct loss of government
controls on production and indirect market demand cre-
ated by decreased production due to political disruption
in Vietnam and Laos, formerly the chief suppliers to
Europe and North America [9,10]. By this time, Iran had
significantly decreased opium production due to blockage
of trade routes and severe punishment for drug-related
convictions by the new theocratic regime [10]. Restric-
tions on cultivation and refining in Pakistan in the mid to
late 1990's led to the shift of these activities to Afghani-
stan, resulting in the creation of new trade routes into
Pakistan and Central Asia [11]. Opium cultivation was
further encouraged by warlord commanders in constant
conflict with each other following the Russian retreat in
1989. These commanders required economic support for
military actions in response to loss of United States fund-
ing to Najibullah's government in 1991 [12]. During the
mujaheddin [freedom fighters] era, opium and heroin pro-
duction rose steadily with Afghanistan becoming the lead-
ing global supplier, overtaking Burma in the mid-1990's
[13]. Since this time, either Afghanistan or Burma have
contributed the greatest percentage to the world's opium
market, with Afghanistan being the single largest country
producer for the last four years.
The rise of the Taliban regime was marked with steadily
increasing opium production, despite their pledge to
"cleanse Afghanistan of the poisoned poppies" [14].
Increased opium production has been attributed to eco-
nomic realities faced by the Taliban, who received little
external donor support due to international sanctions.
The Taliban charged a 10% tax to opium farmers, netting
$20 million or more each year, and controlled the opiate
trade, with confiscated boxes bearing the words, "Not for
use by Muslims" [15,16]. However, in 2000, the Taliban,
now controlling the majority of Afghanistan, banned
opium cultivation and enforced harsh punitive measures
against drug use, which included maiming the hands of
drug users. These steps, as well as severe drought in
Afghanistan, were highly effective in reducing the amount
of available opiates in the world market, resulting in drug
shortages in Europe and a ten-fold increase in price
[13,17]. Some believe the move was economically moti-
vated to increase price, but this will remain open to debate
as the Taliban were deposed in 2001 [18,19].
Within the year following removal of the Taliban regime,
opium production recovered to near-record levels, with
3400 and 3600 metric tons produced in 2002 and 2003,
respectively. In 2003, total income to opium farmers
alone was equal to half of the legal gross domestic product
and illustrated that, despite Hamid Karzai's declaration of
a jihad [holy war] on opium, regional commanders con-
tinue to rely on opium production and trafficking to
maintain their strongholds [13]. Opium cultivation has
been revived in southern provinces and introduced in
eastern and northern Afghan provinces, likely due to eco-
nomic consideration as it is at least twelve times more
profitable than wheat [13,20,21]. In 2004, a UNODC sur-
vey was performed to assess opium production within
Afghanistan [21]. The study reports opium cultivation in
all provinces with 2.9% of all arable land devoted to this
purpose, though as much as 29% is cultivated in some
provinces. The estimated crop for 2004 would have
exceeded the record set in 1999 had drought and other
plant stressors not compromised crop yields [21]. Despite
these losses, Afghanistan produced 87% of the global
opium supply last year; this supply increase may be
impacting price as gross income per cultivated hectare
decreased 64% and gross family income among opium
farmers decreased 56%, based on study interviews [21].
The price per kilogram has decreased in all markets,
though prices are markedly different between provinces
with lowest prices noted in the northeastern areas [21].
UNODC posits that the declining price may also be due to
declining quality (reduced opium content per gram in irri-
gated fields), competitive lower prices in Tajikistan, and
the small number of traders that control the market.
The UNODC survey used satellite images as well as pho-
tos and GPS coordinates covering 16% of all arable land
in 10 provinces; a survey of farmers was also performed by
sampling approximately 8% of all villages in 21 prov-
inces, representing 19% of the total cultivation area [21].
This is the largest study performed to date for estimation
of opium cultivation in Afghanistan; however, significant
regional differences may not have been adequately
assessed in areas under-sampled by the survey. These esti-
mates resulted in a wide confidence interval (109,000–
152,000 hectares), though would still represent a 36%
increase in cultivation at lowest estimate. Additionally,
while opium production is believed to have increased, the
study states that production is based on robust estimates
as obtaining objective evidence on a crop that is not
openly traded is not possible.
This increase in production and the portent of further pro-
duction increases, indicated by the increasing number of
farmers and hectares, has lead Antonio Maria Costa, the
executive director of UNODC, to state that,Page 2 of 6
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cal progress towards democracy culminated in the near
plebiscite election of President Karzai. For this splendid
accomplishment we all salute President Karzai's courage
and determination. Yet, opium cultivation, which has
spread like wildfire throughout the country, could ulti-
mately incinerate everything – democracy, reconstruction
and stability."[21].
Current Opium Laws
As the government of Afghanistan develops, laws concern-
ing opium production and use have been the subject of
multiple decrees, often with external influence. The
United Nations Security Council Resolution and the Bonn
Agreement of 2001 stated that the new government of
Afghanistan should respect international obligations and
cooperate with the international community in the fight
against terrorism, drugs and organized crime [22]. In
2002, Hamid Karzai, at the time the appointed interim
leader of the Transitional Islamic State of Afghanistan
(TISA), issued decrees banning cultivation, production,
drug abuse and trafficking of narcotic drugs, and the
simultaneous implementation of an eradication cam-
paign by the government [22].
Use of opium products is illegal in Afghanistan; convic-
tion results in a three-month prison sentence.
Opium Use in Afghanistan
Historically, opium has been used in Afghan communi-
ties as medication for different conditions, particularly
pain and respiratory complaints. Opium use also has a
traditional role in the societies of some groups [23]. There
are few national estimates of opium use in Afghanistan;
the highest regional use is noted in northeastern Bada-
khshan Province along the Tajik border, with 20–30% of
the local population estimated to be addicted. High use
rates have also been reported in districts of Herat and
Farah Provinces [23]. In February 2001, UNODC con-
ducted a study in five remote districts of four provinces.
The estimated total adult population of these five districts
(Khak-e-Jabar, Azro, Hesarak, Gardez, and Sayed Karam)
is 120,000 people. According to key informants, there
were at least 694 opium users, 164 heroin users, 8514
hashish users and 2556 persons using recreational phar-
maceuticals [24]. However, because the interviews were
with a limited number of drug users and key informants,
these figures are only approximations; there is no official
drug user registry in Afghanistan.
Recreational opium use appears to be common in Kabul,
based on data from a recent study conducted by UNODC,
interviewing 100 key informants and 200 drug users [25].
There are estimated to be at least 6,026 heroin users,
10,257 opium users, 26,415 hashish users, 15,526 phar-
maceutical drugs addicts and 8,128 alcohol addicts within
Kabul. However, due to the small numbers of drug users
interviewed and inherent biases introduced from inter-
view of key informants, these numbers are believed to rep-
resent conservative estimates. There are no reports for the
number of drug users in other urban areas.
Although heroin is predominately used by men, multiple
sources document opiate use starting in childhood and
affecting both genders [24,25]. Based on these studies, the
Counter Narcotic Department (CND), the highest drug
control authority under the presidential office, estimates
that there are approximately 500,000 people within
Afghanistan addicted to different psychoactive substances
(Personal Communication, Dr. M. Zafar, Drug Demand
Reduction Officer, CND, October 29, 2004).
Heroin is easily accessible in Afghanistan and there is a
disturbing trend towards injection of heroin alone and in
combination with other substances, linked to returning
refugees importing behaviors from other countries where
injection use is common [25,26]. According to a drug user
in Kabul: "Drugs are like vegetables here. Very cheap and infi-
nitely available"[24]. In Kabul, single use doses of opium
cost about 20–50 Afghanis ($0.50–1.00 US) whereas a
typical dose of heroin costs about 40–50 Afghanis ($1
U.S.) [26]. However, prices are not stable and change with
the seasonal availability of opium and heroin in the local
market. Pharmaceutical opiates and other psychoactive
substances can be easily obtained from the estimated
15,000 registered pharmacies or many unregistered phar-
macies. People can obtain different psychoactive drugs,
sedatives, pain killers and narcotics without a prescription
and in unlimited quantities [26]. As in Pakistan and India,
some pharmacies are reputed to sell buprenorphine (Tem-
gesic) and some addicts report using it, though there is no
documented evidence [12,27]. Needles and other injec-
tion paraphernalia are available over the counter, but
their cost may be prohibitive to drug users who are most
often unemployed. Pharmacies are likely to continue as a
common source of drugs since the Ministry of Public
Health (MOPH) does not currently have the capacity to
monitor pharmacies.
Although problem drug use appears to be increasing in
Afghanistan, addiction treatment remains limited. Medi-
cal services are provided to addicts through both public
and private sectors, which, together, are not able to meet
the demand for services. In the public sector, the National
Mental Health Institutes, under direction of the MOPH,
have functioning treatment and rehabilitation centers in
several Afghan cities. The center in Kabul (Mental Health
Institute) has only 30 treatment slots. (personal commu-
nication, Dr. Khaitab Khakar, Director, MoPH Kabul Men-
tal Health Institute, June 30, 2005) In a few provinces,Page 3 of 6
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ing out-patient services, such as counseling, but these do
not have an in-patient facility.
The private sector also has limited treatment resources,
with only two non-government organizations (NGO) cur-
rently providing in-patient services. The Nejat Center has
ten treatment beds and two outreach teams in each of
their Kabul and Badakhshan locations. According to the
Nejat Center director, Dr. Tareq Suleyman,"We have the
capacity to treat just 20 addicts a month but we have
3,000 people on the waiting list "[28]. Between 2001 and
2003, 4335 drug addicts have been treated, with 956
treated at the Kabul Mental Health Institute and 1308 at
the Nejat Center [28]. Another NGO, Welfare Association
for Afghanistan (WADAN), has a fifteen bed facility for
drug addicts in Gardez, Paktiya Province. The standard of
care for rehabilitation in Afghanistan is a fifteen day in-
patient stay, followed by continued counseling via out-
reach counselors in the home or return visits to the outpa-
tient department. Methadone treatment has not yet been
introduced, though several groups agree that substitution
therapy is needed in this setting.
No data is available on relapse due to lack of a reliable,
functioning follow-up system. Human resources are
scarce for harm reduction activities, like drug demand
reduction and rehabilitation, due to lack of trained staff
and a severe shortage of female health workers and coun-
selors. There are currently a small number needle
exchange programs in Kabul, orchestrated through Zind-
agi Nawin drug counseling programs. (Personal commu-
nication, Dr. M. Ilyas Azami, German Technical
Cooperation, August 16, 2005) NGO activities involved
in harm reduction education are limited, with the major-
ity of their activities conducted in Kabul city, though
counseling and prevention activities are being conducted
by Nejat in Kabul and German Technical Cooperation
(GTZ) with NGO partners SHRO (Herat), Wadan, (Gar-
dez and Kandahar) and KOR in Kabul and Faizabad.
Regional Opium Use and Influential Trends
The experiences and influence of other countries in the
region are an important consideration for predicting
future harm reduction needs and blood-borne infection
rates in Afghanistan. Larger supplies of heroin are antici-
pated to be available in Afghanistan as production
increases and spillover from new trafficking routes threat-
ens to affect a larger number of people by reaching remote
areas of the country.
Data for heroin production within Afghanistan is based
on border seizures. Central Asian countries, particularly
Tajikistan, are reporting record amounts of drug seized,
with the disturbing trend of drug transition from opium
to heroin as early as 2001 [16,29]. Security has increased
at the Iranian border as a part of that country's response to
rising drug use and violence associated with trafficking,
but the heroin demand continues in Iran, driving traffick-
ing activity [2,29]. Additionally, trafficking has increased
to Central Asia and Pakistan, with the risks of transporting
blood-borne pathogens intrinsic to trafficking activities
[29]. Traffickers routinely test the quality of the substance
with the dealer/distributor in the next country, often shar-
ing injection equipment. These activities allow transmis-
sion of infection from areas of presumed higher
prevalence to Afghanistan and could initiate or fuel the
final component of the cycle related to heroin.
The concern for transmission of blood borne viruses in
this context cannot be minimized. Both hepatitis B and C
have measurable documented prevalence in injection
drug users (IDUs) and the general populations of border-
ing countries Pakistan and Uzbekistan [3,30-34]. In Paki-
stan, hepatitis C prevalence ranges from 5.3 to 7% in the
general population, [30-32] 22% in non-injecting heroin
users,[34] and 89% in IDUs [3]. Rising prevalence of hep-
atitis B and C due to injection drug use have been noted
in other Central Asian Republics [30,35]. Central and
South Asia are experiencing a rapid increase in HIV cases
introduced by injection drug use and the commercial sex
trade [7,16,36-38]. The HIV prevalence among IDUs in
neighboring countries is largely unknown. Recently, prev-
alences of 29.8% and 12.1% were reported among intra-
venous drug users in Dushanbe, Tajikistan and Tashkent,
Uzekistan respectively; of all HIV cases in Iran, 65% are
among IDUs [1,39,40]. Injection drug use appears to be
increasing in Afghanistan, raising concerns that a concen-
trated epidemic of HIV will ensue, as IDU and HIV have
been documented to follow overland heroin trafficking
routes [6,19,41].
The epidemic of injection drug use in Central Asia has
been attributed to the poor socioeconomic conditions
and proximity to opium trafficking routes [42]. These fac-
tors may contribute to the increasing number of IDU in
Afghanistan. However, Afghanistan has several other char-
acteristics predisposing its populace to drug addiction and
transition to injecting use. Previous studies have docu-
mented that refugees are at increased risk to adopt drug
use, largely due to poor economic indicators and psycho-
logical changes leading to increased risky behavior
[43,44]. An estimated 3.5 million Afghans have repatri-
ated within the last four years, of whom a significant pro-
portion remain internally displaced [45]. Two recent
studies suggest importation of learned drug use and other
risk behaviors by this vulnerable population [34,46]. New
behaviors learned by Afghan refugees in Pakistan, and, to
a lesser degree, Iran and the Central Asian Republics,
where rates of both injection drug use and blood-bornePage 4 of 6
(page number not for citation purposes)
Harm Reduction Journal 2005, 2:13 http://www.harmreductionjournal.com/content/2/1/13infections are quickly rising, may be impacting drug use
patterns [29,37]. Afghans may be disproportionately at
risk for blood-borne infections resulting from injection
drug use as displaced Afghan drug users exhibited less
knowledge regarding HIV transmission and engage in
high-risk behavior with greater frequency when compared
to Pakistani drug users. A study done among IDU in
Quetta, Pakistan revealed that, of 143 Afghans surveyed,
none used condoms, only 4% had ever heard of HIV/
AIDS, 18% injected drugs, and of those, 72% reported
needle sharing, all of which displayed a significantly
greater degree of risk than their Pakistani counterparts.
Additionally, 41% of Afghan drug users stated they had
engaged the services of commercial sex workers [46].
There have been efforts to increase awareness of blood-
borne infection transmission among vulnerable groups in
Kabul city by several non-government organizations,
including ORA, Nejat Center, and GTZ, as well as by the
Ministry of Public Health and the National HIV/AIDS
Control Program (NACP). The outreach workers affiliated
with these programs have established rapport with several
marginalized risk groups, predominantly drug users. Pre-
liminary findings from an on-going study of blood-borne
infection prevalence among injection drug users in Kabul
indicates that, of 67 surveyed, the majority report not
sharing "works" and purchasing single use syringes from
the pharmacy daily (cost 3 Afghanis = US$0.06). How-
ever, another study surveying high-risk and sentinel pop-
ulation groups in Kabul, Heart, Mazar-i-Sharif, and
Kandahar notes that only approximately 40% of those
surveyed, including drug users, had ever heard of HIV/
AIDS. (Personal communication, John Foran, ActionAid
Afghanistan, August 16, 2005) Prevention messages have
also been disseminated to the general population. The
NACP has engaged the religious community in dialogue
about the risks of HIV to Afghanistan and their role in
community preventive education in a particularly note-
worthy program.
There have been few changes in the number or content of
rehabilitation programs in Kabul city, though some
NGOs wish to initiate substitution therapy following pro-
curement of funding. (Personal communication, Wayne
Bazant, German Technical Cooperation, July 6, 2005)
UNODC is currently conducting a country-wide assess-
ment of drug use, which may also provide compelling evi-
dence for increasing both the available number and
therapeutic options of rehabilitation programs. Addi-
tional in-depth studies of risky behavior, particularly
before and after the introduction of a harm reduction pro-
gram, would provide meaningful data.
Conclusion
Although Afghanistan is a major producer of heroin,
injection drug use appears to be a relatively new phenom-
enon. Greater numbers of heroin users have been
observed following the end of the Taliban regime and the
return of Afghan refugees from neighboring countries
[23]. Although few studies are available, high risk behav-
iors have been documented among Afghan IDUs along
with low HIV/AIDS awareness and virtually no condom
use [46]. The growing number of injection drug users, the
availability of heroin, and small, geographically-limited
number of harm reduction and drug treatment programs
in Afghanistan place the country at great risk for epidem-
ics of blood-borne infection. Further research on blood-
borne infection risk behaviors and seroprevalence among
drug users in Afghanistan would be helpful to better
describe the current situation. Funding of programs to
broaden education programs on HIV/AIDS and viral hep-
atitis, harm reduction, and drug treatment services should
be an urgent priority.
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